Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 191
Aptamer sequence: ACCAACCCTTTACCTCTGAGATCTCCCAAT
Target unique ID: P04585
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_187 PF1-GG > CC Protein POL_HV1H2 > 500 nM 50 mM Tris-HCl, pH 8, 1mM DTT, 80 mM KCl, 6 mM MgCl2 for ten minutes 22554064
Structure information of aptamer
Aptamer Sequence: ACCAACCCTTTACCTCTGAGATCTCCCAAT
The optimal secondary structure in dot-bracket notation: ..............................
The centroid secondary structure in dot-bracket notation: ..............................
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_187 Description PF1-GG > CC
Aptamer chemistry DNA Length 30 nt
GC content 46.7% Molecular weight 9,245.77 Da
Molarity of 1 μg/μl solution 108.16 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted therapy
Sequence ACCAACCCTTTACCTCTGAGATCTCCCAAT
Applications Inhibiting function against the WT HIV-1 RT
Target information
Type Detail Type Detail
Uniprot ID P04585 Protein name Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
Gene name(s) gag-pol Organism Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
Status reviewed in uniprot database Length 1435
Mass 162,042 Activity regulation The viral protease is inhibited by many synthetic protease inhibitors (PIs), such as amprenavir, atazanavir, indinavir, loprinavir, nelfinavir, ritonavir and saquinavir
Involvement in disease N/A Catalytic activity Reaction=Specific for a P1 residue that is hydrophobic, and P1' variable
PDB ID(s)
1A30;1BV7;1BV9;1BVE;1BVG;1BWA;1BWB;1C0T;1C0U;1C1B;1C1C;1DMP;1DTQ;1DTT;1E6J;1EP4;1ESK;1EX4;1EXQ;1FB7;1FK9;1FKO;1FKP;1G6L;1HIV;1HVH;1HVR;1HWR;1HXB;1JKH;1JLA;1JLB;1JLC;1JLE;1JLF;1JLG;1JLQ;1KLM;1LV1;1LW0;1LW2;1LWC;1LWE;1LWF;1NCP;1O1W;1ODW;1ODY;1QBR;1QBS;1QBT;1QBU;1REV;1RT1;1RT2;1RT3;1RT4;1RT5;1RT6;1RT7;1RTD;1RTH;1RTI;1RTJ;1S1T;1S1U;1S1V;1S1W;1S1X;1T05;1TAM;1TKT;1TKX;1TKZ;1TL1;1TL3;1VRT;1VRU;2HND;2HNY;2HNZ;2KOD;2NPH;2OPP;2OPQ;2OPR;2OPS;2RF2;2RKI;2WHH;2WOM;2WON;2YNF;2YNG;2YNH;2YNI;3AO2;3C6T;3C6U;3DI6;3DLE;3DLG;3DM2;3DMJ;3DOK;3DOL;3DOX;3DRP;3DRR;3DRS;3DYA;3E01;3FFI;3I0R;3I0S;3KJV;3KK1;3KK2;3KK3;3KT2;3KT5;3LAK;3LAL;3LAM;3LAN;3LP0;3LP1;3LP2;3M8P;3M8Q;3MEC;3MED;3MEE;3MEG;3N3I;3NBP;3PHV;3QIN;3QIO;3QIP;3T19;3T1A;3TAM;4B3O;4B3P;4B3Q;4I7F;4KSE;4KV8;4NCG;4Q1W;4Q1X;4Q1Y;4Q5M;4QLH;4U1H;4U1I;4U1J;4U7Q;4U7V;5DGU;5DGW;5EU7;5HRN;5HRP;5HRR;5HRS;5IM7;5J2M;5J2N;5J2P;5J2Q;5K14;5KAO;5T82;5TC2;5VZ6;5XOS;5XOT;5YRS;6BJ2;6BJ3;6BSG;6BSH;6BSI;6BSJ;6DIF;6DIL;6DJ1;6DJ2;6DJ5;6DJ7;6DV0;6DV4;6E7J;6E9A;6EWA;6EX9;6GL1;6J1V;6J1W;6OR7;6OTZ;6P1I;6P1X;6P2G;6PYL;6SKK;6SKM;6SKN;6SLQ;6SLU;6SMU;6UIR;6UIS;6UIT;6UJX;6UJY;6UJZ;6UK0;6VPZ;6VQ2;6VQD;6VQE;6VQY;6VQZ;6WAZ;6WB1;6WPF;6WPH;6WPJ;
Function Mediates, with Gag polyprotein, the essential events in virion assembly, including binding the plasma membrane.
Activity data

No relevant experimental diagram

Interaction ID 191
Target type Protein
Target unique ID P04585
Activity > 500 nM
Binding Conditions/Buffer

50 mM Tris-HCl, pH 8, 1mM DTT, 80 mM KCl, 6 mM MgCl2 for ten minutes

Assay

N/A

PubMed ID 22554064
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_185 DNA ACCAAGGCTTTAGGTCTGAGATCTCCCAAT
86.67%
Apta_189 DNA AGGAACCCTTTACCTCTGAGATCTCGGAAT
86.67%
Apta_190 DNA AGGAACCCTTTAGGTCTGAGATCTCGGAAT 80.00%
Apta_191 DNA AGGAAGGCTTTACCTCTGAGATCTCGGAAT 80.00%
Apta_186 DNA AGGAACGCTTTAGGTCTGAGATCTCGGAAT 76.67%
Apta_192 DNA AGGAAGGCTTTAGCTCTGAGATCTCGGAAT 76.67%
Apta_184 DNA AGGAAGGCTTTAGGTCTGAGATCTCGGAAT 73.33%
Apta_188 DNA AAAAAAACTTTAAATCTGAGATCTCAAAAT 73.33%
Apta_204 DNA CCAAGGCTTTAGGTCTGAGATCTCCC 73.33%
Apta_193 DNA AGGAAGGCTTTAGGGTCTGAGATCTCGGAAT 70.97%
Apta_202 DNA AAGGCTTTAGGTCTGAGATCTCGGAAT 70.00%
Apta_215 DNA AGGAAGGCTTTAGGTCCGAGATCTCGGAAT 70.00%
Apta_194 DNA AGGAAGGCTTTAGGGTCTGAGATCTCGGGAAT 68.75%
Apta_195 DNA AGGAAGGCTTTAGGGGTCTGAGATCTCGGAAT 68.75%
Apta_196 DNA AGGAAGGCTTTAGGTCTGAGATCTC 63.33%
Apta_197 DNA GGCTTTAGGTCTGAGATCTCGGAAT 63.33%
Apta_205 DNA TTAAGGCTTTAGGTCTGAGATCTCTT 63.33%
Apta_203 DNA GGAAGGCTTTAGGTCTGAGATCTCGG 60.00%
Apta_206 DNA AGGAAGGGGTCTGAGATCTCGGAAT 56.67%
Apta_1269 DNA TAGCACACAACCCTTTGATTGGGATATCTCATCCCTCG 55.26%